Laboratory Corporation of Ameri (NYSE:LH):
LabCorp is first US laboratory to offer molecular testing with new fully automated cobas 8800 system from Roche.
The company is up from yesterday’s close of $123.95.
The stock last traded at $124.00 a tad below $135.77, the 50 day moving average and a tad under the 200 day moving average of $132.48. The 50 day moving average was down by -8.67% and the 200 day average moved down $-8.48.
The most current P/E ratio is 19.66 and market cap is 12.76B. As of the last earnings report the EPS was $6.31 and is expected to be $8.81 for the current year with 102,900,000 shares currently outstanding. Next quarter’s EPS is forecasted at $2.23 with next year’s EPS anticipated to be $9.74.
Several Wall Street investment firms have weighed in on Laboratory Corporation of Ameri recently. August 16 investment analysts at KeyBanc held the stock rating at “Overweight” but raised the price target from $143.00 to $150.00. On July 28 UBS kept the company rating at “Neutral” and lowered the price target to $137.50 from $155.00.
April 26 investment analysts at Jefferies left the stock rating at “Overweight” and raised the price expectation to $155.00 from $134.00. April 26 investment analysts at Canaccord Genuity maintained a stock rating of “Overweight” and moved up the price target to $155.00 from $145.00.
On April 26 Barclays made no change to the company rating of “Overweight” but moved up the price target to $155.00 from $140.00. On March 15, 2016 Credit Suisse starting coverage on LH with an initial rating of “Outperform” and projecting a price target of $133.00.